Citations

Mayo Clinic

Clear

1572 citation(s) found for "Wu, Samuel".

Maintaining Contact for Effective Mapping and Ablation
Asirvatham, Samuel J. , Kapa, Suraj , Asirvatham, Samuel J

Circulation: Arrhythmia and Electrophysiology | October 21, 2014 | Volume: 7 | Issue: 5 | Pages: 781-784

10.1161/circep.114.002204 | PMID 25336364 Get It

Editor’s Perspective: In the Middle
Asirvatham, Samuel J. , Stevenson, William G. , Asirvatham, Samuel J

Circulation: Arrhythmia and Electrophysiology | October 21, 2014 | Volume: 7 | Issue: 5 | Pages: 982-983

10.1161/circep.114.002202 | PMID 25336369 Get It

Femoral Approach to Lead Extraction
Mulpuru, Siva K. , Hayes, David L. , Osborn, Michael J., Asirvatham, Samuel J. , Asirvatham, Samuel J

Journal of Cardiovascular Electrophysiology | October 13, 2014 | Volume: 26 | Issue: 3 | Pages: 357-361

10.1111/jce.12564 | PMID 25311643 Get It

Femoral ExtractionLaser and radiofrequency energy–assisted lead extraction has greatly facilitated this complex procedure. Although success rates are high, in some instances alternate methods of extraction are required. In this review, we discuss techniques for femoral extraction of implanted leads and retained fragments. The major tools available, including commonly used snares and delivery tools, are discussed. We briefly describe combined internal jugular and femoral venous extraction approaches, as well as complimentary utilization of more than one technique via the femoral vein. Animated and procedural sequences are included to help the reader visualize the key components of these techniques.
Successful Percutaneous Epicardial Access in Challenging Scenarios
Ebrille, Elisa , Killu, Ammar M. , Anavekar, Nandan S., Packer, Douglas L. , Munger, Thomas M. , Asirvatham, Samuel J. , Friedman, Paul A. , McLeod, Christopher J. , Asirvatham, Samuel J

Pacing and Clinical Electrophysiology | September 16, 2014 | Volume: 38 | Issue: 1 | Pages: 84-90

10.1111/pace.12503 | PMID 25223580 Get It

BackgroundThis case‐series highlights strategies used for successful epicardial access in challenging cases.Percutaneous epicardial access has become a valuable tool for mapping and ablating arrhythmias. However, this technique can be especially difficult in certain circumstances and is frequently avoided.MethodsAll cases of epicardial access for ablation from our institution were reviewed searching for exceptionally difficult cases in patients with complex pericardial and thoracic anatomy. The successful strategies are characterized in this report.ResultsAmong 144 patients who underwent an epicardial ablation procedure between January 2004 and June 2013, four required unconventional approaches for epicardial access for ventricular tachycardia ablation. Two patients (one with previous cardiac surgery and one with prior pericardial effusion) had substantial fibrous pericardial adhesions with no virtual pericardial space and required adhesiolysis. One patient, status postpartial colectomy, underwent computed tomography‐guided intercostal epicardial access due to the presence of bowel throughout the subdiaphragmatic space in the upper abdomen. The fourth patient had partial congenital absence of the pericardium and underwent epicardial access through the creation of a subxiphoid window. All epicardial accesses were successful and performed without major complication.ConclusionsWith precise procedural planning and cardiac imaging, percutaneous epicardial access is feasible even in patients with significant anatomical challenges.
The IRF5–TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share
Kottyan, Leah C. , Zoller, Erin E., Bene, Jessica, Lu, Xiaoming , Kelly, Jennifer A. , Rupert, Andrew, Lessard, Christopher J. , Vaughn, Samuel , Marion, Miranda C. , Namjou, Bahram , Adler, Adam, Rasmussen, Astrid , Glenn, Stuart B., Montgomery, Courtney G. , Hirschfield, Gideon M. , Coltescu, Catalina, Amos, Chris, Ice, John A. , Registry, for UK Primary Sjögren's Syndrome, Rischmueller, Maureen , Brun, Johan G. , Gøransson, Lasse G. , Harboe, Erna, Omdal, Roald, Cunninghame‐Graham, Deborah S., Vyse, Tim J., Miceli‐Richard, Corinne , Lessard, James, Wahren‐Herlenius, Marie , Kvarnström, Marika , Illei, Gabor G. , Witte, Torsten, Jonsson, Roland , Nordmark, Gunnel , Ng, Wan‐Fai , Registry, for UK Primary Sjögren's Syndrome, Anaya, Juan‐Manuel , Rhodus, Nelson L., Segal, Barbara, Guthridge, Joel M. , Scofield, R. Hal , Alarcón‐Riquelme, Marta E. , Bae, Sang‐Cheol , Boackle, Susan A., Criswell, Lindsey A. , Gilkeson, Gary S. , Jacob, Chaim O., Kimberly, Robert P. , Brown, Elizabeth E. , Edberg, Jeffrey C., Alarcón, Graciela S. , Reveille, John D. , Vilá, Luis M. , Petri, Michelle , Niewold, Timothy B. , Stevens, Anne M., Tsao, Betty P. , Gorlova, Olga Y. , Wakeland, Ward, Radstake, Timothy R. D. J., Martín, Jose‐Ezequiel , Martı́n, Javier , Siminovitch, Katherine, Sivils, Kathy L., Gaffney, Patrick M. , Langefeld, Carl D. , Harley, John B., Kaufman, Kenneth M. , Niewold, Timothy, Weirauch, Matthew T. , Xie, Gang , Li, He , Nath, Swapan Kumar , Mariette, Xavier , Bowman, Simon , Registry, for UK Primary Sjögren's Syndrome, Lester, Sue , Brennan, Michael Thomas , Eriksson, Per , Registry, for UK Primary Sjögren's Syndrome, Merrill, Joan T. , James, Judith A. , Kamen, Diane L. , Ramsey‐Goldman, Rosalind , Freedman, Barry I. , Ying, Binwu , Mayes, Maureen D. , Hirschfield, Gideon M , Kottyan, Leah C , Guthridge, Joel M

Human Molecular Genetics | September 10, 2014 | Volume: 24 | Issue: 2 | Pages: 582-596

10.1093/hmg/ddu455 | PMID 25205108 Get It

ICE Imaging of the Left Atrial Appendage
Asirvatham, Samuel J. , DeSimone, Christopher V. , Asirvatham, Samuel J

Journal of Cardiovascular Electrophysiology | September 2, 2014 | Volume: 25 | Issue: 11 | Pages: 1272-1274

10.1111/jce.12536 | PMID 25181549 Get It

Bone Conduction Calibration: Current Status
Dirks, Donold D., Lybarger, Samuel F., Olsen, Wayne O., Billings, Bradley L.

Journal of Speech and Hearing Disorders | August 26, 2014 | Volume: 44 | Issue: 2 | Pages: 143-155

10.1044/jshd.4402.143 | PMID 502484 Get It

Attempts to specify normal threshold sensitivity by bone conduction have been unsuccessful because of problems in obtaining reliable measurements from commercially available artificial mastoids. Recent design modifications incorporated in the Bruel and Kjaer 4930 artificial mastoids have resulted in greater uniformity among these units. However, the new design has resulted in impedances that are higher than those recommended in current standards. Bone-conduction thresholds referenced to measurements made on B x00026 K 4930 artificial mastoids with the new design were performed on 60 normal listeners by three participating laboratories. The results are reported for consideration in the development of a reference threshold for hearing by bone conduction.
Electroporation
Asirvatham, Samuel J. , Kapa, Suraj , DeSimone, Christopher V. , Asirvatham, Samuel J

Circulation: Arrhythmia and Electrophysiology | August 19, 2014 | Volume: 7 | Issue: 4 | Pages: 573-575

10.1161/circep.114.001999 | PMID 25140018 Get It

Editor’s Perspective: Electrocardiogram Mapping–Reentry
Asirvatham, Samuel J. , Stevenson, William G. , Asirvatham, Samuel J

Circulation: Arrhythmia and Electrophysiology | August 19, 2014 | Volume: 7 | Issue: 4 | Pages: 760-761

10.1161/circep.114.001928 | PMID 25140022 Get It

Late Aminophylline Reversal of Regadenoson Stress Testing in Patients with End Stage Renal Disease
Abudiab, Muaz M. , Freiman, Samuel Unzek

World Journal of Nuclear Medicine | August 18, 2014 | Volume: 13 | Issue: 02 | Pages: 142-143

10.4103/1450-1147.139148 | PMID 25191132 Get It

Regadenoson is a widely used and well-tolerated vasodilator agent for pharmacologic stress myocardial perfusing imaging. In patients at higher risk of adverse reactions such as those with end stage renal disease, it can be reversed with early administration of aminophylline. However, little is known about late administration of aminophylline. This case report describes the efficacy of late aminophylline use in patients with end stage renal disease. Possible explanations for the prolonged pharmacodynamic effect of regadenoson in this group are discussed.